Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38663205 | 0.92 | NPC1 (0.42) | ACHENPC1RAB9ASMN1; SMN2TLR2 | |
| SCHEMBL38661897 | 0.90 | ACHE (0.46) | ACHEEPHX2TLR2 | |
| SCHEMBL38661368 | 0.87 | ACHE (0.47) | ACHEEPHX2TLR2EPHX1 | |
| SCHEMBL31229156 | 0.87 | ACHE (0.52) | ACHEEPHX2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL38661458 | 0.86 | ACHE (0.47) | ACHEEPHX2TLR2 | |
| SCHEMBL38662061 | 0.85 | CYP3A4 (0.40) | ACHEEPHX2TLR2 | |
| SCHEMBL38663264 | 0.83 | TLR2 (0.38) | ACHENPC1RAB9ASMN1; SMN2TLR2 | |
| SCHEMBL38661468 | 0.82 | TLR2 (0.46) | ACHENPC1RAB9ASMN1; SMN2TLR2 | |
| SCHEMBL31229126 | 0.81 | ACHE (0.46) | ACHEEPHX2 | |
| SCHEMBL7749335 | 0.80 | ACHE (0.70) | ACHEEPHX2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098671-A1 | CATIONIC LIPIDS AND PREPARATION METHOD THEREOF | RIBOX THERAPEUTICS HK LIMITED (CN) | 2026-05-15 | — | — | WO | disclosed |